Latest Insider Transactions at Pacira Bio Sciences, Inc. (PCRX)
This section provides a real-time view of insider transactions for Pacira Bio Sciences, Inc. (PCRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Pacira BioSciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Pacira BioSciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 19
2022
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
2,199
-8.99%
|
$142,935
$65.51 P/Share
|
|
Jan 19
2022
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,199
+8.25%
|
$83,562
$38.35 P/Share
|
|
Jan 18
2022
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
224
-1.26%
|
$14,112
$63.55 P/Share
|
|
Jan 18
2022
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
2,500
-14.16%
|
$160,000
$64.97 P/Share
|
|
Jan 18
2022
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+12.41%
|
$25,000
$10.81 P/Share
|
|
Jan 18
2022
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
23,440
-26.09%
|
$1,523,600
$65.69 P/Share
|
|
Jan 18
2022
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,440
+13.28%
|
$1,007,920
$43.44 P/Share
|
|
Jan 11
2022
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+12.06%
|
$150,000
$10.81 P/Share
|
|
Jan 04
2022
|
Anthony Molloy Chief Lgl & Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+10.11%
|
-
|
|
Jan 04
2022
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+11.66%
|
-
|
|
Dec 17
2021
|
Mark Froimson Director |
SELL
Bona fide gift
|
Direct |
400
-6.34%
|
-
|
|
Nov 22
2021
|
Charles Anthony Laranjeira Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+18.25%
|
$330,000
$44.1 P/Share
|
|
Nov 16
2021
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+13.75%
|
$150,000
$10.81 P/Share
|
|
Nov 04
2021
|
Roy Winston Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.71%
|
$480,000
$48.15 P/Share
|
|
Aug 03
2021
|
Jonathan Slonin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+15.95%
|
-
|
|
Aug 03
2021
|
Roy Winston Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+12.06%
|
-
|
|
Jul 29
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
90
-0.68%
|
$5,400
$60.81 P/Share
|
|
Jul 29
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
90
+0.68%
|
$900
$10.81 P/Share
|
|
Jul 28
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
2,410
-15.49%
|
$144,600
$60.85 P/Share
|
|
Jul 28
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
2,410
+13.41%
|
$24,100
$10.81 P/Share
|
|
Jul 02
2021
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
421
-2.35%
|
$24,839
$59.76 P/Share
|
|
Jun 11
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
2,003
-13.59%
|
$118,177
$59.85 P/Share
|
|
Jun 10
2021
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
5,689
-10.49%
|
$341,340
$60.0 P/Share
|
|
Jun 09
2021
|
Laura Brege Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+10.6%
|
-
|
|
Jun 09
2021
|
Christopher Christie Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+31.43%
|
-
|
|
Jun 09
2021
|
Mark Froimson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+14.46%
|
-
|
|
Jun 09
2021
|
Yvonne Greenstreet Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+8.1%
|
-
|
|
Jun 09
2021
|
Paul J Hastings Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+13.99%
|
-
|
|
Jun 09
2021
|
Mark A. Kronenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+5.99%
|
-
|
|
Jun 09
2021
|
Charles Anthony Laranjeira Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+21.42%
|
-
|
|
Jun 09
2021
|
John P Phd Longenecker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+5.36%
|
-
|
|
Jun 09
2021
|
Donald C. Manning Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+16.89%
|
-
|
|
Jun 09
2021
|
Roy Winston Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+18.4%
|
-
|
|
Jun 09
2021
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+20.02%
|
-
|
|
Jun 09
2021
|
David M Stack CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
17,800
+18.4%
|
-
|
|
Jun 09
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+15.0%
|
-
|
|
Jun 09
2021
|
Charles A. Reinhart Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+16.3%
|
-
|
|
Jun 09
2021
|
Max Reinhardt President, Rest of World |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+28.57%
|
-
|
|
Jun 09
2021
|
Dennis Mc Loughlin Chief Customer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+15.17%
|
-
|
|
Jun 09
2021
|
Gary W Pace Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+0.82%
|
-
|
|
Jun 08
2021
|
Donald C. Manning Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,600
-9.95%
|
$158,600
$61.14 P/Share
|
|
Jun 07
2021
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
2,278
-17.83%
|
$136,680
$60.5 P/Share
|
|
Jun 04
2021
|
Paul J Hastings Director |
SELL
Open market or private sale
|
Direct |
630
-10.3%
|
$39,060
$62.19 P/Share
|
|
Jun 04
2021
|
Charles Anthony Laranjeira Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,117
-10.18%
|
$129,137
$61.04 P/Share
|
|
Jun 04
2021
|
Dennis Mc Loughlin Chief Customer Officer |
SELL
Open market or private sale
|
Direct |
1,895
-6.44%
|
$115,595
$61.04 P/Share
|
|
Jun 04
2021
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
1,222
-8.73%
|
$74,542
$61.04 P/Share
|
|
Jun 04
2021
|
Charles A. Reinhart Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,648
-9.65%
|
$161,528
$61.04 P/Share
|
|
Jun 04
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,047
-7.94%
|
$63,867
$61.04 P/Share
|
|
Jun 04
2021
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
14,905
-19.6%
|
$909,205
$61.04 P/Share
|
|
Jun 04
2021
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
3,930
-15.79%
|
$239,730
$61.04 P/Share
|